Shanghai, China China Pacific Insurance is the famous Corporate Investor, which was founded in 1991. The leading representative office of defined Corporate Investor is situated in the Shanghai. The fund was located in Asia if to be more exact in China.
Among the various public portfolio startups of the fund, we may underline Metromile, Shanghai Cell Therapy Group, Atzuche Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Therapeutics, Health Care.
The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2016. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the China Pacific Insurance, startups are often financed by New Enterprise Associates, Index Ventures, SV Angel. The meaningful sponsors for the fund in investment in the same round are Hearst Ventures, Xiran Capital, SV Angel. In the next rounds fund is usually obtained by Tokio Marine Holdings, Section 32, NEA.
Related Funds
| Fund Name | Location |
| Avala Capital | Berlin, Berlin, Germany |
| Baltisches Haus | - |
| Bluecap Mobile | Bangalore, India, Karnataka |
| Brooks Brothers | New York, New York, United States |
| Buckeye Oil Producing Company | - |
| F1 Solutions | - |
| FTW Ventures | California, San Francisco, United States |
| Ignition Group | Italy, Lombardia, Milano |
| John Bendheim Enterprises | - |
| Kubo Group | Missouri, Netherlands, United States |
| Marathon Venture Partners | China, Shanghai |
| Persistent | Switzerland, Zürich, Zurich |
| Pivot Partners | England, London, United Kingdom |
| Renaissance Technologies | New York, New York, United States |
| Scale Finance | Durham, North Carolina, United States |
| Shenzhen Cema Xinnengyuan Touzi Hehuo Qiye | China, Guangdong, Tianjin |
| Springtide | Cambridge, Massachusetts, United States |
| Turing Asset Management | China, Guangdong, Shenzhen |
| Veron International | China, Hong Kong, Hong Kong Island |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tripod Preclinical Research Laboratories | $5M | 12 Apr 2023 | Nanjing, Jiangsu, China | ||
Nest | 07 Jun 2022 | Wuxi, Anhui, China | |||
Miao | $77M | 02 Apr 2019 | Dongcheng District, Beijing, China | ||
Shanghai Cell Therapy Group | $143M | 18 Dec 2018 | Jiading District, China | ||
Atzuche | $61M | 24 Feb 2017 | Shanghai, China | ||
E Yang Che | $15M | 03 Mar 2016 | Shanghai, China | ||
| $30M | 22 Jan 2016 | Dongcheng District, Beijing, China | |||
Atzuche | $46M | 30 Nov 2015 | Shanghai, China | ||
C-Health | $463K | 01 Apr 2015 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tripod Preclinical Research Laboratories | $5M | 12 Apr 2023 | Nanjing, Jiangsu, China | ||
Nest | 07 Jun 2022 | Wuxi, Anhui, China | |||
Miao | $77M | 02 Apr 2019 | Dongcheng District, Beijing, China | ||
Shanghai Cell Therapy Group | $143M | 18 Dec 2018 | Jiading District, China | ||
Atzuche | $61M | 24 Feb 2017 | Shanghai, China | ||
E Yang Che | $15M | 03 Mar 2016 | Shanghai, China | ||
| $30M | 22 Jan 2016 | Dongcheng District, Beijing, China | |||
Atzuche | $46M | 30 Nov 2015 | Shanghai, China | ||
C-Health | $463K | 01 Apr 2015 | Shanghai, China |
